{"_id":"6c656c93-c6be-46ed-b6e6-4d605dda93b0","country":"United Kingdom","entryDate":"2022-03-15","path":"/current-portfolio/fundamental-vr/","sdg":[],"sector":"Healthcare","title":"Fundamental VR","organizationData":{},"fundData":[{"path":"/current-portfolio/funds/lsp-hef-2/","title":"LSP HEF 2","preamble":"LSP HEF 2 (Health Economic Fund) seeks to invest in health care technology companies in late-stage development or early-stage commercialization. Products or technologies need to have the potential to improve the quality of healthcare and lower the cost of care at the same time. LSP HEF 2’s geographical focus is primarily Europe and the US. \n","currency":"eur","email":"rdekeyser@lspvc.com","heading":"Investments range between EUR 10 million and EUR 30 million","indexing":"index,follow","launchDate":"2018","size":"280","status":"active"}]}
{"_id":"1108b4d9-6102-497c-b1b9-21b51b63dcc9","country":"Sweden","entryDate":"2019-01-16","path":"/current-portfolio/karo-healthcare/","sdg":[],"sector":"Healthcare","title":"Karo Healthcare","organizationData":{"uuid":"da941769-eda4-4d29-9e72-4427d9f504af","name":"Karo Healthcare","homepage_url":"https://www.karopharma.com","country_code":"SWE","city":"Stockholm","founded_on":"1987-01-01","short_description":"Karo Healthcare is a health care center that develops and markets products to pharmacies.","employee_count":"101-250"},"fundData":[{"path":"/current-portfolio/funds/eqt-viii/","title":"EQT VIII","preamble":"EQT VIII makes control equity investments as well as significant influence investments in companies with strong market positions, significant potential for revenue and earnings growth, strong cash flows and a solid platform that can retain and attract high-quality management. The geographical focus will primarily be Northern Europe and the fund will mainly focus on investments in the Healthcare, TMT and Services sectors.\n","currency":"eur","email":"peter.veldman@eqtfunds.com","heading":"Investments range between EUR 150 million and EUR 1,000 million","indexing":"index,follow","launchDate":"2018","size":"10910","status":"fullyinvested"}]}
{"_id":"b133af2d-27dd-4a0c-b41e-a13994aa76f6","country":"Germany","entryDate":"2021-03-06","path":"/current-portfolio/ariceum-therapeutics/","sdg":[],"sector":"Healthcare","title":"Ariceum Therapeutics","organizationData":{"uuid":"e9901b38-f393-4072-8b05-e2da8d7d0e94","name":"Ariceum Therapeutics","homepage_url":"https://ariceum-therapeutics.com/","country_code":"DEU","city":"Berlin","founded_on":"2021-01-01","short_description":"Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.","employee_count":"11-50","num_funding_rounds":"2","last_funding_on":"2023-04-18","total_funding_usd":"51760502"},"fundData":[{"path":"/current-portfolio/funds/lsp-7/","title":"LSP 7","preamble":"LSP 7 seeks to invest in early-to-late-stage life sciences companies, developing novel and ground-breaking new medicines and technologies that provide solutions to unmet medical needs. LSP 7’s geographical focus is primarily Europe and occasionally the US. \n","currency":"eur","email":"rkuijten@lspvc.com","heading":"Investments range between EUR 30 million and EUR 60 million","indexing":"index,follow","launchDate":"2021","size":"1000","status":"active"}]}
{"_id":"2ad70473-2924-4d48-9e09-938ee2926b69","country":"United States","entryDate":"2020-08-14","path":"/current-portfolio/workwave/","sdg":[],"sector":"Technology","title":"WorkWave","organizationData":{"uuid":"a0af0753-feb7-ab7d-d2f3-95722adad41d","name":"WorkWave","homepage_url":"https://www.workwave.com/","country_code":"USA","city":"Holmdel","founded_on":"1984-01-01","short_description":"WorkWave provides cloud-based software solutions that support every stage of a service business’s life cycle.","employee_count":"1001-5000","num_funding_rounds":"5","last_funding_on":"2022-03-30","total_funding_usd":"8300000"},"fundData":[{"path":"/current-portfolio/funds/eqt-ix/","title":"EQT IX","preamble":"EQT IX makes control and co-control equity investments in mid-to-large sized companies with attractive market positions, significant potential for revenue and earnings growth, strong cash flows and a solid platform that can retain and attract high-quality management.\n","currency":"eur","email":"peter.veldman@eqtfunds.com","heading":"Investments range between EUR 150 million and EUR 1,200 million","indexing":"index,follow","launchDate":"2020","size":"15600","status":"active"},{"path":"/current-portfolio/funds/eqt-viii/","title":"EQT VIII","preamble":"EQT VIII makes control equity investments as well as significant influence investments in companies with strong market positions, significant potential for revenue and earnings growth, strong cash flows and a solid platform that can retain and attract high-quality management. The geographical focus will primarily be Northern Europe and the fund will mainly focus on investments in the Healthcare, TMT and Services sectors.\n","currency":"eur","email":"peter.veldman@eqtfunds.com","heading":"Investments range between EUR 150 million and EUR 1,000 million","indexing":"index,follow","launchDate":"2018","size":"10910","status":"fullyinvested"}]}
